Whenever you hear Vivek Ramaswamy talk about taking down the system, keep in mind he worked as an investment partner at a hedge fund before founding biotech, Roivant Sciences, in 2014
He stepped down as CEO in 2021, but remained chairman until 2023
He isn't changing anything… pic.twitter.com/PjCPWLVIOc
— Financelot (@FinanceLancelot) August 20, 2023
Vivek Ramaswamy made his money scamming investors with a $2 billion IPO for an Alzheimer drug that had already failed certification 4 times…
He bought it, rebranded it knowing it wouldn't pass. Then he took the company public with a $2 billion IPO & cashed out. pic.twitter.com/UvORNmA9KW
— Financelot (@FinanceLancelot) August 21, 2023